Literature DB >> 28604666

Prospective computerized monitoring of cognitive functioning before and after blood and marrow transplantation.

K L Votruba1, F Hoodin2,3, B Giordani1, R Kentor3, D R Couriel4, C L Kitko5.   

Abstract

Mesh：

Year:  2017        PMID： 28604666     DOI： 10.1038/bmt.2017.105

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Reliability of repeated cognitive assessment of dementia using a brief computerized battery.

Authors:  Dustin Hammers; Elizabeth Spurgeon; Kelly Ryan; Carol Persad; Judith Heidebrink; Nancy Barbas; Roger Albin; Kirk Frey; David Darby; Bruno Giordani
Journal:  Am J Alzheimers Dis Other Demen       Date:  2011-06-01       Impact factor: 2.035

2.  Validity of a brief computerized cognitive screening test in dementia.

Authors:  Dustin Hammers; Elizabeth Spurgeon; Kelly Ryan; Carol Persad; Nancy Barbas; Judith Heidebrink; David Darby; Bruno Giordani
Journal:  J Geriatr Psychiatry Neurol       Date:  2012-06       Impact factor: 2.680

3.  Prospective evaluation of neurological complications after allogeneic bone marrow transplantation.

Authors:  P Sostak; C S Padovan; T A Yousry; G Ledderose; H-J Kolb; A Straube
Journal:  Neurology       Date:  2003-03-11       Impact factor: 9.910

4.  The effect of histidine on mental fatigue and cognitive performance in subjects with high fatigue and sleep disruption scores.

Authors:  Ikuko Sasahara; Naoko Fujimura; Yoshizu Nozawa; Yasufumi Furuhata; Hitoshi Sato
Journal:  Physiol Behav       Date:  2015-04-25

5.  Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation.

Authors:  M A Andrykowski; E M Altmaier; R L Barnett; T G Burish; R Gingrich; P J Henslee-Downey
Journal:  Bone Marrow Transplant       Date:  1990-10       Impact factor: 5.483

6.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.

Authors:  Karen L Syrjala; Samantha B Artherholt; Brenda F Kurland; Shelby L Langer; Sari Roth-Roemer; JoAnn Broeckel Elrod; Sureyya Dikmen
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

Review 7.  The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature.

Authors:  Marina G Falleti; Antonietta Sanfilippo; Paul Maruff; LeAnn Weih; Kelly-Anne Phillips
Journal:  Brain Cogn       Date:  2005-06-21       Impact factor: 2.310

8.  Cognitive testing in early-phase clinical trials: development of a rapid computerized test battery and application in a simulated Phase I study.

Authors:  Alex Collie; Amanda Darekar; Georges Weissgerber; Melvin K Toh; Peter J Snyder; Paul Maruff; John P Huggins
Journal:  Contemp Clin Trials       Date:  2006-11-06       Impact factor: 2.226

9.  Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant.

Authors:  Karen L Syrjala; Sureyya Dikmen; Shelby L Langer; Sari Roth-Roemer; Janet R Abrams
Journal:  Blood       Date:  2004-07-13       Impact factor: 22.113

10.  Subtle memory decline over 12 months in mild cognitive impairment.

Authors:  P Maruff; A Collie; D Darby; J Weaver-Cargin; C Masters; Jon Currie
Journal:  Dement Geriatr Cogn Disord       Date:  2004-08-13       Impact factor: 2.959
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.